These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 10200578

  • 1. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
    Ruiz-Ruiz MC, López-Rivas A.
    Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
    [Abstract] [Full Text] [Related]

  • 2. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Nov 15; 60(22):6537-43. PubMed ID: 11103825
    [Abstract] [Full Text] [Related]

  • 3. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T, Fujiwara T, Morimoto Y, Shao J, Nishizaki M, Kadowaki Y, Hizuta A, Owen-Schaub LB, Roth JA, Tanaka N.
    Oncogene; 1999 Apr 01; 18(13):2189-99. PubMed ID: 10327065
    [Abstract] [Full Text] [Related]

  • 4. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L.
    Cell Death Differ; 1998 Sep 01; 5(9):735-42. PubMed ID: 10200532
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis of haematopoietic cells upon thymidylate synthase inhibition is independent of p53 accumulation and CD95-CD95 ligand interaction.
    Muñoz-Pinedo C, Oliver FJ, López-Rivas A.
    Biochem J; 2001 Jan 01; 353(Pt 1):101-108. PubMed ID: 11115403
    [Abstract] [Full Text] [Related]

  • 6. The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis.
    Müller M, Scaffidi CA, Galle PR, Stremmel W, Krammer PH.
    Eur Cytokine Netw; 1998 Dec 01; 9(4):685-6. PubMed ID: 9889415
    [Abstract] [Full Text] [Related]

  • 7. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
    Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R.
    Cancer Res; 1997 Aug 15; 57(16):3331-4. PubMed ID: 9269989
    [Abstract] [Full Text] [Related]

  • 8. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis.
    Aguilar-Lemarroy A, Gariglio P, Whitaker NJ, Eichhorst ST, zur Hausen H, Krammer PH, Rösl F.
    Oncogene; 2002 Jan 10; 21(2):165-75. PubMed ID: 11803460
    [Abstract] [Full Text] [Related]

  • 9. Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells.
    Sheard MA, Uldrijan S, Vojtesek B.
    Cancer Res; 2003 Nov 01; 63(21):7176-84. PubMed ID: 14612511
    [Abstract] [Full Text] [Related]

  • 10. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA, Lupu R.
    Int J Mol Med; 2005 Jan 01; 15(1):33-40. PubMed ID: 15583825
    [Abstract] [Full Text] [Related]

  • 11. Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program.
    Ruiz-Ruiz C, Muñoz-Pinedo C, López-Rivas A.
    Cancer Res; 2000 Oct 15; 60(20):5673-80. PubMed ID: 11059759
    [Abstract] [Full Text] [Related]

  • 12. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
    Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM.
    Cancer Res; 1997 Sep 01; 57(17):3823-9. PubMed ID: 9288794
    [Abstract] [Full Text] [Related]

  • 13. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
    Juang SH, Pan WY, Kuo CC, Liou JP, Hung YM, Chen LT, Hsieh HP, Chang JY.
    Biochem Pharmacol; 2004 Jul 15; 68(2):293-303. PubMed ID: 15194001
    [Abstract] [Full Text] [Related]

  • 14. CD95 ligand expression in dedifferentiated breast cancer.
    Müschen M, Moers C, Warskulat U, Niederacher D, Betz B, Even J, Lim A, Josien R, Beckmann MW, Häussinger D.
    J Pathol; 1999 Nov 15; 189(3):378-86. PubMed ID: 10547600
    [Abstract] [Full Text] [Related]

  • 15. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V, Slomianny C, Hondermarck H, Le Bourhis X.
    Exp Cell Res; 2004 Aug 15; 298(2):560-73. PubMed ID: 15265702
    [Abstract] [Full Text] [Related]

  • 16. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
    Mezzanzanica D, Balladore E, Turatti F, Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F, Oggionni M, Pilotti S, Canevari S.
    Clin Cancer Res; 2004 Aug 01; 10(15):5202-14. PubMed ID: 15297424
    [Abstract] [Full Text] [Related]

  • 17. Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells.
    Brás A, Albar JP, Leonardo E, de Buitrago GG, Martínez-A C.
    Cell Death Differ; 2000 Mar 01; 7(3):262-71. PubMed ID: 10745271
    [Abstract] [Full Text] [Related]

  • 18. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
    Cerrato JA, Khan T, Koul D, Lang FF, Conrad CA, Yung WK, Liu TJ.
    Int J Oncol; 2004 Feb 01; 24(2):409-17. PubMed ID: 14719118
    [Abstract] [Full Text] [Related]

  • 19. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
    Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG.
    Cancer Res; 2002 May 01; 62(9):2644-9. PubMed ID: 11980662
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.